Piper Sandler analyst Clarke Jeffries raised the firm’s price target on Lightspeed (LSPD) to $17 from $15 and keeps a Neutral ...

Piper Sandler analyst Jason Bednar assigned a Buy rating to Beyond Air (XAIR – Research Report) today and set a price target of $1.00.

In a report released today, David Westenberg from Piper Sandler assigned a Hold rating to Elanco Animal Health (ELAN – Research Report), ...

AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

This financial health positions Stryker to pursue deals that could ... which corresponds with Piper Sandler's increased price target and optimistic outlook. The company's year-to-date price ...

On Tuesday, Piper Sandler reiterated its Overweight rating ... leading to an increase in the company's full-year guidance. Glaukos announced its third-quarter earnings, showcasing a significant ...

A preview of the next edition of BioWorld, ...

Q3 2024 Earnings Call Transcript October 25, 2024 Operator: Good morning. And welcome to the Piper Sandler Companies’ Third Quarter 2024 Earnings Conference Call. Today’s call is being recorded and ...

Shares of US banks including Citigroup Inc., JPMorgan Chase and Co. and Goldman Sachs Group Inc. surged in premarket trading ...

Piper Sandler analyst Brent Bracelin maintained an ... outlook is not "a demand issue" and the second half of the fiscal year could see a reacceleration. Wedbush on MSFT: The first-quarter ...

Piper Sandler Companies (NYSE ... Still much better than last year, but ECM and DCM is a pretty low visibility business as we mentioned in our last coverage, and some sequential slowdown is ...

“We are confident that the regulatory pendulum will swing back somewhat,” Mark Fitzgibbon, an analyst at Piper Sandler, said ...